Amyotrophic Lateral Sclerosis
FY21 Therapeutic/Biomarker Pilot Trial Award
The list of Fiscal Year 2021 Amyotrophic Lateral Sclerosis Research Program Therapeutic/Biomarker Pilot Trial Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
|Columbia University Medical Center||Neil Shneider|
|Massachusetts General Hospital||Mark Albers|
Last updated Monday, January 3, 2022